2025-08-19 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc. (TDOC) based on the provided data, presented in English with a focus on key metrics and insights.

## Teladoc Health Inc. (TDOC) Analysis

**Company Overview:** Teladoc Health Inc. is a telehealth and virtual healthcare company offering a range of services through its platform.

### 1. Performance vs. S&P 500 (VOO)

**Key Numbers:**

*   TDOC Cumulative Return: -65.12%
*   VOO Cumulative Return: 101.92%
*   Divergence (TDOC - VOO): -155.7
*   Divergence Range: Max 285.0, Min -155.7
*   Relative Divergence: 0.0

**Analysis:**

TDOC has significantly underperformed the S&P 500 (VOO) over the period considered. The divergence of -155.7 indicates a substantial gap in returns.  A relative divergence of 0.0 means that the current divergence is at the lowest point in the historical range. The data suggests that TDOC has been substantially underperforming the S&P 500.

**Alpha/Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha    | Beta   | Cap(B) |
|------------|----------|----------|----------|--------|--------|
| 2015-2017  | 76.0%    | 60.6%    | 50.0%    | -0.0   | 6.2    |
| 2016-2018  | 128.0%   | 59.3%    | 110.0%   | -0.0   | 8.8    |
| 2017-2019  | 176.0%   | 59.3%    | 147.0%   | 0.4    | 14.8   |
| 2018-2020  | 237.0%   | 64.0%    | 217.0%   | 0.1    | 35.3   |
| 2019-2021  | -83.0%   | 64.0%    | -132.0%  | 0.1    | 16.2   |
| 2020-2022  | -295.0%  | 81.3%    | -297.0%  | 0.0    | 4.2    |
| 2021-2023  | -488.0%  | 81.3%    | -506.0%  | -0.6   | 3.8    |
| 2022-2024  | -111.0%  | 81.3%    | -137.0%  | -0.8   | 1.6    |
| 2023-2025  | -36.0%   | 75.5%    | -89.0%   | -0.8   | 1.3    |

*   **CAGR:**  Early periods showed very high growth, but recent periods have experienced significant negative CAGR.
*   **MDD:** Maximum Drawdown remains high, indicating significant volatility and risk.
*   **Alpha:** Alpha is largely negative in recent years, indicating underperformance relative to a benchmark.
*   **Beta:** Beta values are generally low (close to zero or negative), which might indicate low market sensitivity, but the negative values in recent periods suggest the stock moves inversely to the market.
*   **Cap(B):** Market Cap has significantly decreased in recent years.

### 2. Recent Price Action

**Key Numbers:**

*   Current Price: 7.49
*   Previous Close: 7.52
*   Change: -0.4%
*   5-Day Moving Average: 7.324
*   20-Day Moving Average: 7.4455
*   60-Day Moving Average: 7.589

**Analysis:**

The current price is slightly down from the previous close. The 5-day moving average is below the 20-day and 60-day moving averages, suggesting a short-term downtrend. The price is below the 60-day MA, which could be seen as a bearish signal.

### 3. Market Risk Indicator (MRI) and Other Indicators

**Key Numbers:**

*   MRI: 0.3285 (Low Risk)
*   RSI: 48.97
*   PPO: 0.558
*   Hybrid Signal: cash_1%_Buy 90% of cash (378 shares - Safe - MRI:0.33)
*   20-Day Relative Divergence Change: -0.3 (Negative - Short-term Decline)
*   Expected Return: -9994.1%

**Analysis:**

*   **MRI:**  The Market Risk Indicator is in the "Low Risk" range.
*   **RSI:** RSI is near 50, indicating neutral momentum.
*   **PPO:** PPO is slightly positive, suggesting a minor bullish trend.
*   **Hybrid Signal:** The signal suggests a small buy with a high allocation of cash, implying a cautious approach.
*   **Relative Divergence Change:** The negative change indicates a recent underperformance relative to the benchmark.
*   **Expected Return:** The extremely negative expected return is a very strong indication that, under current conditions, the model predicts considerable long-term underperformance compared to the S&P 500. This should be interpreted with caution, as such extreme values can sometimes indicate issues with the model or extraordinary circumstances.
*   **Change:** The 'change' value of -0.4% isn't dramatically large, so it doesn't point to an immediate major volatility event.

### 4. Recent News & Significant Events

*   **Volatility:** Stock has shown notable volatility.
*   **Analyst Discussions:** Recent performance and outlook are being discussed.
*   **Business Developments:** Major business developments or regulatory changes.
*   **Risk & Opportunities:** Market experts highlight both risks and opportunities.

**Analysis:**

The news headlines suggest that TDOC is currently experiencing volatility and is under scrutiny from analysts. Keep a close eye on company announcements and industry trends.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출        |
|------------|-------|-------------|
| 2025-07-30 | -0.19 | 0.63 B$     |
| 2025-05-01 | -0.53 | 0.63 B$     |
| 2024-10-31 | -0.19 | 0.64 B$     |
| 2024-08-01 | -4.92 | 0.64 B$     |
| 2025-07-30 | -4.92 | 0.64 B$     |

**Analysis:**

EPS is negative in all reported quarters, which is concerning. Revenue has been relatively stable but doesn't seem to be growing significantly. The significant drop in EPS for the 2024-08-01 and 2025-07-30 periods is a red flag.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $0.63B  | 69.85%        |
| 2025-03-31 | $0.63B  | 68.73%        |
| 2024-12-31 | $0.64B  | 70.50%        |
| 2024-09-30 | $0.64B  | 71.94%        |
| 2024-06-30 | $0.64B  | 70.73%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE      |
|------------|---------|----------|
| 2025-06-30 | $1.42B  | -2.30%   |
| 2025-03-31 | $1.43B  | -6.52%   |
| 2024-12-31 | $1.49B  | -3.25%   |
| 2024-09-30 | $1.51B  | -2.21%   |
| 2024-06-30 | $1.50B  | -55.77%  |

**Analysis:**

*   **Revenue:**  Revenue is relatively stable.
*   **Profit Margin:** Profit margins are high.
*   **Equity:** Equity has been decreasing slightly.
*   **ROE:** Return on Equity is negative, indicating that the company is not generating profits from shareholders' investments. The very negative ROE in 2024-06-30 is a major concern.

### 7. Overall Analysis

TDOC is facing significant challenges.

*   **Underperformance:**  The stock has severely underperformed the S&P 500, with a large negative divergence.
*   **Negative Earnings:** EPS and ROE are consistently negative, raising concerns about profitability.
*   **Price Action:** Recent price action indicates a short-term downtrend.
*   **Mixed Signals:** While the MRI suggests low market risk, the extremely negative expected return and recent earnings data point to significant underlying issues.
*   **Volatility:** The news headlines highlight volatility and analyst concerns.
*   **Cautious Signals:** The hybrid signal suggests a very cautious approach.

**Conclusion:**

Based on the provided data, TDOC appears to be a high-risk investment.  The persistent negative earnings, underperformance relative to the market, and decreasing equity are significant red flags.  While the high profit margins are a positive aspect, they are not enough to offset the other negative indicators.  Investors should exercise extreme caution and conduct thorough due diligence before considering an investment in TDOC. It's important to closely monitor future earnings reports, company announcements, and industry trends.
